I am often asked what my thoughts are on the “fentanyl epidemic” and what impact it will have on Nova Scotia so here it is: Fentanyl is of great concern due to its potency and accessibility vs other prescription opioids. The healthcare system created a huge market of opioid dependant people which organize crime is… Continue reading Illicit Fentanyl’s confirmed arrival in Nova Scotia
Interviews include: Rob Mulloy – GPDOTS enforcement consultant Ray Wagner – Lawyer heading class action suit against Purdue Pharma Nadine Wentzell – Consultant & former narcotics inspector
On March 7th 2016 GPDOTS wrote the Nova Scotia Minister of Health & Wellness , College of Physicians & Surgeons , and the Prescription Monitoring Program regarding our concerns with the programs ability to identify over prescribing. Shortly after our letter Minister Leo Glavine announced he would be ordering a full review of the program.… Continue reading GPDOTS letter of concern regarding the Prescription Monitoring Program
